FDA advisers review data on potential 1st US gene therapy – Minneapolis Star Tribune
|
FDA advisers review data on potential 1st US gene therapy
Minneapolis Star Tribune The therapy could be the first of a wave of cancer treatments custom-made to target a patient’s cancer. Called CAR-T, it involves removing immune cells from a patients’ blood, reprogramming them to create an army of attack cells and putting them back … |
Medscape |
Stem Cells in Sports Medicine: Ready for Prime Time?
Medscape The man sitting across from me said he was desperate. Osteoarthritis was causing excruciating pain in his knee. But he had found a solution: For $18,000, a doctor in Mexico would inject stem cells from a Russian embryo. What did I think? “I don’t know … |
U.S. News & World Report |
CRISPR Stocks: How to Invest in a Medical Miracle
U.S. News & World Report In 2012, Dr. Jennifer Doudna of the University of California-Berkeley and Emmanuelle Charpentier of Umeå University in Sweden discovered what is known as the CRISPR-Cas9 genome editing technique. It was a monumental discovery: The technique is … |